BIOMAT Database Logo BIOMAT Database Logo

Discovery of diarylpyridine derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. 2009

Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing 100850, China.

Two series (4 and 5) of diarylpyridine derivatives were designed, synthesized, and evaluated for anti-HIV-1 activity. The most promising compound, 5e, inhibited HIV-1 IIIB, NL4-3, and RTMDR1 with low nanomolar EC50 values and selectivity indexes of >10,000. The results of this study indicate that diarylpyridine can be used as a novel scaffold to derive a new class of potent NNRTIs, active against both wild-type and drug-resistant HIV-1 strains.

UI MeSH Term Description Entries
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D024882 Drug Resistance, Viral The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation. Antiviral Drug Resistance,Antiviral Drug Resistances,Drug Resistances, Viral

Related Publications

Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.
August 2012, ACS medicinal chemistry letters,
Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
Novel Cyclopropyl-Indole Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.
June 2012, ACS medicinal chemistry letters,
Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
February 2004, Journal of medicinal chemistry,
Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
Discovery of piperidin-4-yl-aminopyrimidine derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
June 2015, European journal of medicinal chemistry,
Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
Synthesis of novel uracil non-nucleoside derivatives as potential reverse transcriptase inhibitors of HIV-1.
November 2009, Archiv der Pharmazie,
Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
November 2022, Molecules (Basel, Switzerland),
Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
February 2017, Bioorganic chemistry,
Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
[Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].
November 2009, Yao xue xue bao = Acta pharmaceutica Sinica,
Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase.
August 2008, Bioorganic & medicinal chemistry letters,
Xingtao Tian, and Bingjie Qin, and Hong Lu, and Weihong Lai, and Shibo Jiang, and Kuo-Hsiung Lee, and Chin Ho Chen, and Lan Xie
Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors: A Combinatorial Approach.
December 2017, Biochemistry. Biokhimiia,
Copied contents to your clipboard!